This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stroke, Volume 55, Issue Suppl_1 , Page AWP77-AWP77, February 1, 2024. Purpose:The quality of acute stroke care can be improved through the nationwide compulsory quality assessment. Acute stroke quality assessment (ASQA) covers most acute stroke patients treated in acute care hospitals in Korea.
18, 2024 — Abbott recently announced new data for the Amplatzer Amulet Left Atrial Appendage (LAA) Occluder to treat people with atrial fibrillation (AFib) who are at an increased risk of stroke. A statistically significant lower number of fatal or disabling strokes with Amulet (22 vs. 39). tim.hodson Tue, 11/19/2024 - 15:57 Nov.
years after SAVR to assess their outcomes. Secondary outcomes included rates of reoperation, infective endocarditis, stroke, and hospital admissions for heart failure. The research team followed these patients for a median time of 2.4 years after TAVR and 4.9 The primary focus was on 5-year survival rates.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP98-ATMP98, February 1, 2024. Introduction:Functional outcomes after acute stroke (AS) are related to the initial neurological severity. We defined MNS as a score of ≤5 points on the National Institutes of Health Stroke Scale.
The ‘1–3–6–12 days rule’, based on expert consensus and referring to stroke severity, was used in clinical practice to initiate OAC after acute ischaemic stroke or transient ischaemic attack (TIA) since publication in 2013. Trial registration number NCT02306824.
The TAILORED-AF trial, highlights AIs ability to help physicians treat cardiovascular disease and improve patient outcomes. Atrial fibrillation, when left untreated, doubles the risk of heart-related deaths and is associated with a 5-fold increased risk for stroke. Am J Cardiol 2013; 112:11421147. adult population.
This study sought to analyse temporal trends in patient demographics, procedural characteristics, and clinical outcomes at an Irish tertiary referral centre. Patient and procedural characteristics and clinical outcomes were compared across groups. Clinical outcomes at 1-year follow-up did not change significantly over time.
BackgroundThe impact of atrial fibrillation (AF) on the clinical outcomes in patients with acute ischemic stroke (AIS) who received endovascular thrombectomy remains unclear. Data were meta‐analyzed to compare the outcomes among patients with AIS with and without AF who received endovascular thrombectomy. 1.08]; [95% PI, 0.77–1.11]),
Stroke, Volume 55, Issue Suppl_1 , Page ATP193-ATP193, February 1, 2024. The primary outcome was a 90-day modified Rankin Scale (mRS) of 0-3. The primary outcome was a 90-day modified Rankin Scale (mRS) of 0-3. Recanalization status and MT attempt number were not related to secondary outcomes except for 90-day mortality.
Stroke: Vascular and Interventional Neurology, Ahead of Print. BACKGROUNDAs the number of thrombectomy passes increases during endovascular therapy (EVT) for acute stroke, neurointerventionalists must weigh the risks of potential complications against the risk of failing to recanalize the affected vessel. 60.3]; and 5.26 [1.12–24.8],
Background Insights on the differences in clinical outcomes, quality of life (QoL) and health resource utilisation (HRU) with different levels of care available to post-acute myocardial infarction (AMI) populations in rural and urban settings are limited. to 1.15) for the composite of CV death, AMI and stroke.
Stroke, Volume 55, Issue Suppl_1 , Page ATP272-ATP272, February 1, 2024. These populations usually lack primary stroke prevention knowledge tailored to their individual risk factors.Methods/Approach:Cornwell Health conducted 5 didactic sessions with these goals in focus. questions on the pre-survey to 6.5 ± 1.0 on the post-survey.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Mechanical thrombectomy (MT) in eligible patients is proven to improve outcomes and is ow standard of care for acute ischemic stroke. IntroductionStroke is a leading cause of mortality and morbidity worldwide and the risk increases with age.
Stroke, Volume 55, Issue Suppl_1 , Page AWP215-AWP215, February 1, 2024. Introduction:Acute ischemic stroke (AIS) patients often require multiple passes during mechanical thrombectomy (MT) to open the vessel. Primary outcome was 90- day modified Rankin Scale (mRS) 0-2. Yet, at times, even numerous passes are unsuccessful.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionIntracranial atherosclerosis (ICAS) is a leading global cause of stroke. 1‐year rate of stroke and death in stented patients [5]. The role of intracranial stenting in ICAS remains uncertain.
Stroke, Ahead of Print. BACKGROUND:This study aimed to assess the effects of left ventricular diastolic dysfunction (LVDD) on vascular outcomes among patients with stroke of noncardioembolic origins.METHODS:This prospective observational study enrolled 563 patients with noncardioembolic stroke (mean age, 67.9 men and 33.3%
Stroke, Volume 55, Issue Suppl_1 , Page ATP204-ATP204, February 1, 2024. Background:Automated stroke solutions in developing countries have the potential to reduce healthcare gaps. Based on the consensus of the neuroradiologists, these cases included 151 ischemic strokes, 27 ICHs >0.4 ml, 1 ICH <0.4
The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrial fibrillation procedures. Am J Cardiol 2013; 112:1142–1147. 1 Approximately 33 million patients worldwide are living with AFib.
Stroke, Volume 55, Issue Suppl_1 , Page A59-A59, February 1, 2024. Introduction:Many patients are taking antiplatelet medications when an acute stroke occurs. The exposure of interest was pre-stroke antiplatelet use categorized as none, single (SAPT), and dual antiplatelet therapy (DAPT). no antiplatelet, 36.7% SAPT, and 6.4%
Stroke, Volume 56, Issue Suppl_1 , Page A66-A66, February 1, 2025. Introduction:Many patients may not recognize the initial symptoms of TIA or stroke and delay seeking urgent medical care, leading to missed treatments and worse outcomes. Sensitivity to a combined diagnosis of TIA or stroke was also calculated.
Stroke, Volume 55, Issue Suppl_1 , Page ATP158-ATP158, February 1, 2024. However, it is unclear whether these assays associate with long term ICH outcomes. Poor 6-month neurological outcome was defined as modified Rankin Scale (mRS) 4-6. Poor 6-month outcome was seen in 61%. 1.10, p=0.05, respectively).
All patients with AF in the National Patient Register and the National Dispensed Drug Register with concomitant use of amiodarone and warfarin or apixaban between 1 June 2013 and 31 December 2018 were included. The primary outcome was major bleeding resulting in hospitalisation based on International Classification of Diseases (ICD)-10 codes.
Stroke, Volume 55, Issue Suppl_1 , Page ATP237-ATP237, February 1, 2024. Background:While traditional risk factors are chronic in nature, it is difficult to predict the risk of stroke with respect to time. Identifying certain acute risk factors, particularly associated with a health service contact, may help to prevent stroke.
“Receiving this CE mark certification for our Zio monitor and ZEUS system reflects our team’s commitment to delivering the highest quality services as we seek to drive better health outcomes and more equitable access for patients around the globe. million ambulatory cardiac monitoring tests performed annually. Turakhia, M. Mensah, AH.
Stroke, Volume 55, Issue Suppl_1 , Page A137-A137, February 1, 2024. Introduction:Within 5 years of a stroke, approximately 25% of patients will have a recurrent event. Despite this benefit, 50% of patients with hypertension remain uncontrolled after a stroke. YNHHS has 5 hospitals and a large outpatient network.
Primary outcomes included receipt of medication(s) associated with the management of the following poststroke complications: arousal/fatigue, spasticity, mood, sleep, neurogenic bladder, neurogenic bowel, and seizure. Before matching, the final cohort consisted of 348 286 patients with first‐time stroke.
Evaluate the benefit in important cardiovascular outcomes and safety in elderly patients of a blood pressure control ≤ 130mmHg compared to standard of care.Methods:The research was performed in PubMed, EMBASE, Scielo, LILACS, and Cochrane Central Register of Controlled Trials (CENTRAL) from January 1st, 2013 to May 1st, 2023.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. The primary endpoint was excellent functional outcome defined as modified Rankin Scale (mRS) ≤2 at 90 days after MT.ResultsIn the pilot study, we included 318 patients, with 142 (45%) having mRS≤ 2 after 90 days, and the mortality rate was 24%.
Stroke, Volume 56, Issue Suppl_1 , Page ATP217-ATP217, February 1, 2025. Introduction:Craniocervical arterial dissection (CCAD) accounts for only a small proportion of ischemic stroke, but it represents 20 to 25% of cases among younger adults. After 6 months post-stroke, the median mRS was 1 (IQR: 3.00), with 73.9%
3 Patients with ASCVD are at a higher risk for major adverse cardiovascular events (MACE) including heart attack or myocardial infarction (MI), stroke, and cardiovascular (CV) death.4 Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. 1.65]), or had a stroke or transient ischemic attack were more likely to quit smoking as compared with those who underwent elective percutaneous coronary intervention or had a new diagnosis of peripheral artery disease (hazard ratio, 1.20 [95% CI, 1.17–1.22]).Conclusions:Only
Stroke, Volume 55, Issue Suppl_1 , Page ATP8-ATP8, February 1, 2024. The study presented intracranial aneurysms after microsurgical and/or endovascular treatment from January 1, 2013 to December 31, 2022. The primary outcome was the incidence of periprocedural cerebral infarction. vs 35.7 %, 10.8 % vs 5.7%, and 28.2%
Among 16 150 REGARDS participants between 2013 and 2016, 8319 (51.5%) and 8569 (53.1%) had an indication for antihypertensive and statin medication, respectively, and pharmacy proximity data. Although, in this US cohort, outcomes were similar for adults living in high or low pharmacy proximity census tracts.
METHODS:Participants were followed from randomization in October 2013 to September 2023 to ascertain MACE, testing for CHD, and changes in risk factors. The primary outcome was time to first MACE, defined as cardiovascular death, nonfatal myocardial infarction, coronary revascularization, and nonfatal stroke. 48% male).
Stroke, Volume 55, Issue Suppl_1 , Page ATMP79-ATMP79, February 1, 2024. Introduction:Incident intracerebral hemorrhage (ICH) is an uncommon medical event that can lead to devastating outcomes, including death. CMBs result from irregularities in brain vessel structure due to chronic hypertension and cerebral amyloid angiopathy.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Thus, there is a need to study and comprehend the management strategies and outcomes of these cases. IntroductionSubarachnoid hemorrhage (SAH) has an estimated prevalence of 7.9 per 100,000 person yearsi.
Ancel Keyes in 1963 published pivotal research that for the first time associated the diet with improved health outcomes, more specifically, showed a correlation between the traditional Mediterranean diet and a lower risk of coronary heart disease. This study helped to solidify the place of the Mediterranean diet in the medical community.
“This study suggests that digital heart health management tools can make a significant, sustainable impact across these risk factors, and ultimately help people take control of their heart attack and stroke risk.” “An Of 102,475 participants, 49.1% were female.
Stroke-volume:50 ml. Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease. Left ventricular end-diastolic volume: 99 ml. Left ventricular systolic volume: 49 ml. Left ventricular ejection fraction:50 %. Normal wall thickness. References: 1.
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BACKGROUND:Atrial fibrillation (AF) is known to be associated with increased risks of stroke and death, but contemporary studies of this association are lacking. We evaluated trends in stroke and death among Medicare beneficiaries with AF between 2013 and 2019.METHODS:Medicare
Background Hypertension is a risk factor for bleeding events and is included in the HAS-BLED (Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile INR, Elderly, Drugs/Alcohol concomitantly) score.
Stroke, Volume 54, Issue 12 , Page 3002-3011, December 1, 2023. BACKGROUND:There is limited information on the delivery of acute stroke therapies and secondary preventive measures and clinical outcomes over time in young adults with acute ischemic stroke. Outcome data were available from 2011.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content